These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10386503)

  • 1. Antioxidant therapy for coronary artery disease: don't paint the walls without treating the termites!
    Ewy GA
    Arch Intern Med; 1999 Jun; 159(12):1279-80. PubMed ID: 10386503
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Ricciardi MJ; Davidson CJ
    N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
    Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
    Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
    [No Abstract]   [Full Text] [Related]  

  • 4. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
    März W
    MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
    Mikhailidis DP; Wierzbicki AS
    Curr Med Res Opin; 2002; 18(4):215-9. PubMed ID: 12201622
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
    Stone PH; Lloyd-Jones DM; Johnstone M; Carlson W; Rubenstein J; Creager M; Frei B; Sopko G; Clark ME; Maccallum G; Kinlay S; Orav J; Selwyn AP
    Am Heart J; 2004 May; 147(5):875-82. PubMed ID: 15131545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease].
    Scheen AJ
    Rev Med Liege; 2005 Apr; 60(4):264-7. PubMed ID: 15943105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention versus medical therapy for coronary heart disease.
    Maron DJ
    Curr Atheroscler Rep; 2000 Jul; 2(4):290-6. PubMed ID: 11122756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density-lipoprotein cholesterol goals for patients with coronary disease: treating between the lines.
    Waters DD; Hsue PY
    Circulation; 2001 Nov; 104(22):2635-7. PubMed ID: 11723009
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy and clinical trials.
    Bachorik PS
    Curr Opin Lipidol; 1998 Oct; 9(5):515-7. PubMed ID: 9812209
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 15. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Cohen DJ; Carrozza JP; Baim DS
    N Engl J Med; 1999 Dec; 341(24):1853-4; author reply 1854-5. PubMed ID: 10610464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile].
    MMW Fortschr Med; 2005 Mar; 147(12):4. PubMed ID: 15832778
    [No Abstract]   [Full Text] [Related]  

  • 17. [AVERT [The Atorvastatin versus Revascularization Treatment]].
    Mokuno H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():436-41. PubMed ID: 11347110
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
    Rader DJ; Davidson MH; Caplan RJ; Pears JS
    Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Am J Cardiol; 2003 Mar; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine statin treatment after acute coronary syndromes?
    Acevedo M; Sprecher DL; Lauer MS; Francis G
    Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.